Novartis adds again to siRNA pipeline with second deal in a day
The transaction with siRNA specialist Argo includes $160m upfront, in addition to milestone and option payments that could…
Roche’s Gen 6 Troponin T test accurately diagnosing heart attacks
Roche Holdings AG reported results from its TSIX study which demonstrated that its sixth-generation Troponin T test is…
Novartis nabs cardio drug with $1.4bn Tourmaline buy
Novartis has bulked up its cardiology pipeline with a $1.4 billion takeover of Tourmaline Bio and its phase…
Diseases of Aging and Regenerative medicine (DARe) research at Novartis
Age-related diseases, including neurodegenerative diseases and cardiovascular and metabolic diseases, account for a substantial and rising portion of…